---
title: Determination of "borderline resectable" pancreatic cancer - A global assessment
  of 30 shades of grey
date: '2023-08-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37558564/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230810180951&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Interobserver variability among radiologists and surgeons
  globally is high, calling into question the consistency of clinical decision making
  for patients with PDAC and suggesting that central review may be required for studies
  of neoadjuvant or adjuvant approaches in future as well as ongoing quality control
  initiatives, even amongst experts in the ...'
disable_comments: true
---
CONCLUSION: Interobserver variability among radiologists and surgeons globally is high, calling into question the consistency of clinical decision making for patients with PDAC and suggesting that central review may be required for studies of neoadjuvant or adjuvant approaches in future as well as ongoing quality control initiatives, even amongst experts in the ...